John G. Stratton - 30 Jun 2022 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Reporting relationship: Director
Issuer ticker: ABT
Reported as of: 30 Jun 2022
Net transaction value: +$32,921
SEC form: 4
Accepted by SEC: 01 Jul 2022, 16:28:36 UTC
Prior SEC filing: 21 Jun 2022
Next SEC filing: 20 Sep 2022
Source filing: View source filing
Reporting owner signature: /s/ John G. Stratton by Jessica H. Paik, Attorney-in-Fact

Key filing fact

John G. Stratton filed Form 4 for ABBOTT LABORATORIES (ABT) on 01 Jul 2022.

Key facts

This page summarizes John G. Stratton's Form 4 filing for ABBOTT LABORATORIES (ABT).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 01 Jul 2022, 16:28.

Change

Previous filing in this sequence was filed on 21 Jun 2022.
Current net transaction value: +$32,921.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ABT transaction Derivative

Stock Equivalent Units

Award

Transaction value: $32,921
Shares: +303
Change %: +4%
Price: $108.65
Shares after: 7,859
Date: 30 Jun 2022
Ownership: Direct
Underlying class: Common Shares
Underlying amount: 303
Exercise price
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

Footnote F2

Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.